New developments in diagnostics and therapeutics for EGFR+ NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

• Evaluate recent advances in the diagnosis and management for EGFR-positive NSCLC
• Describe how new developments might be integrated into clinical practice

Co-chairs:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)

Faculty:

• Enriqueta Felip (Spain)
• Albrecht Stenzinger (Germany)

This educational activity has been awarded 2 CPD points by CPDUK, a globally recognised provider of CPD.